[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2015 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-Feb-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Dec-2015 [#4]
Profit Trend
QoQ- -7.28%
YoY- -10.44%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 2,141,608 2,181,982 2,236,780 2,189,312 2,012,216 1,969,498 1,887,616 8.75%
PBT 90,597 96,050 106,152 112,722 118,673 127,336 154,448 -29.85%
Tax -28,252 -27,828 -32,272 -28,138 -27,282 -30,200 -26,744 3.71%
NP 62,345 68,222 73,880 84,584 91,390 97,136 127,704 -37.91%
-
NP to SH 61,913 66,748 73,516 84,044 90,642 96,022 127,176 -38.03%
-
Tax Rate 31.18% 28.97% 30.40% 24.96% 22.99% 23.72% 17.32% -
Total Cost 2,079,262 2,113,760 2,162,900 2,104,728 1,920,825 1,872,362 1,759,912 11.72%
-
Net Worth 530,907 524,041 515,906 529,482 534,070 527,991 528,173 0.34%
Dividend
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Div 44,889 46,604 41,417 77,674 79,389 72,469 72,494 -27.28%
Div Payout % 72.50% 69.82% 56.34% 92.42% 87.59% 75.47% 57.00% -
Equity
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Net Worth 530,907 524,041 515,906 529,482 534,070 527,991 528,173 0.34%
NOSH 258,979 258,913 258,859 258,915 258,880 258,819 258,908 0.01%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin 2.91% 3.13% 3.30% 3.86% 4.54% 4.93% 6.77% -
ROE 11.66% 12.74% 14.25% 15.87% 16.97% 18.19% 24.08% -
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
RPS 826.94 842.74 864.09 845.57 777.28 760.95 729.07 8.73%
EPS 23.91 25.78 28.40 32.46 35.01 37.10 49.12 -38.03%
DPS 17.33 18.00 16.00 30.00 30.67 28.00 28.00 -27.31%
NAPS 2.05 2.024 1.993 2.045 2.063 2.04 2.04 0.32%
Adjusted Per Share Value based on latest NOSH - 259,064
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
RPS 148.60 151.40 155.20 151.91 139.62 136.65 130.97 8.75%
EPS 4.30 4.63 5.10 5.83 6.29 6.66 8.82 -37.97%
DPS 3.11 3.23 2.87 5.39 5.51 5.03 5.03 -27.36%
NAPS 0.3684 0.3636 0.358 0.3674 0.3706 0.3663 0.3665 0.34%
Price Multiplier on Financial Quarter End Date
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Date 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 -
Price 5.58 5.50 5.76 6.36 6.50 7.13 6.00 -
P/RPS 0.67 0.65 0.67 0.75 0.84 0.94 0.82 -12.56%
P/EPS 23.34 21.33 20.28 19.59 18.56 19.22 12.21 53.84%
EY 4.28 4.69 4.93 5.10 5.39 5.20 8.19 -35.04%
DY 3.11 3.27 2.78 4.72 4.72 3.93 4.67 -23.68%
P/NAPS 2.72 2.72 2.89 3.11 3.15 3.50 2.94 -5.03%
Price Multiplier on Announcement Date
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Date 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 17/08/15 18/05/15 -
Price 5.70 5.62 5.60 6.19 6.50 5.65 6.91 -
P/RPS 0.69 0.67 0.65 0.73 0.84 0.74 0.95 -19.15%
P/EPS 23.84 21.80 19.72 19.07 18.56 15.23 14.07 41.98%
EY 4.19 4.59 5.07 5.24 5.39 6.57 7.11 -29.64%
DY 3.04 3.20 2.86 4.85 4.72 4.96 4.05 -17.36%
P/NAPS 2.78 2.78 2.81 3.03 3.15 2.77 3.39 -12.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment